Andrew J. Leidner

Centers for Disease Control and Prevention

Also affiliated with National Center for Immunization and Respiratory Diseases

Social SciencesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Societal Costs of a Measles Outbreak

PEDIATRICS(2021)10.1542/peds.2020-027037

Top 16%

1.3DataRank

Top 16%34 citations

Alan Melnick, Paul A. Gastañaduy, Meagan Kay, Jeff Harbison, Andrew J. Leidner +5 more

Papers

Driven by 17 papers — median percentile 84. Top paper: “Societal Costs of a Measles Outbreak”.

Societal Costs of a Measles Outbreak

PEDIATRICS(2021)10.1542/peds.2020-027037

Top 16%

1.3DataRank

Top 16%34 citations

Alan Melnick, Paul A. Gastañaduy, Meagan Kay, Jeff Harbison, Andrew J. Leidner +5 more

Cost-effectiveness of vaccinating adults aged 60 years and older against respiratory syncytial virus

Vaccine(2024)10.1016/j.vaccine.2024.126294

N/A

0.907DataRank · unranked

21 citations

Lisa A. Prosser, Angela M. Rose, Kerra Mercon, Ismael R. Ortega‐Sanchez, Andrew J. Leidner +8 more

A Review of Measles Outbreak Cost Estimates From the United States in the Postelimination Era (2004–2017): Estimates by Perspective and Cost Type

Clinical Infectious Diseases(2020)10.1093/cid/ciaa070

N/A

0.621DataRank · unranked

62 citations

Andrew J. Leidner, Paul A. Gastañaduy, Jamison Pike

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States

Vaccine(2023)10.1016/j.vaccine.2023.03.045

N/A

0.464DataRank · unranked

21 citations

Charles Stoecker, Wei Xing, Bo‐Hyun Cho, Andrew J. Leidner, Miwako Kobayashi +1 more

Insurance reimbursements for recombinant zoster vaccine in the private sector

Vaccine(2021)10.1016/j.vaccine.2021.07.050

N/A

0.312DataRank · unranked

7 citations

Zhaoli Tang, Angela Guo, Tara C. Anderson, Yuping Tsai, Andrew J. Leidner

Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines

Applied Health Economics and Health Policy(2022)10.1007/s40258-022-00718-z

N/A

0.208DataRank · unranked

3 citations

Andrew J. Leidner, Harrell W. Chesson, Charles Stoecker, Scott D. Grosse, Jamison Pike

Cost-effectiveness of dengue vaccination in Puerto Rico

PLoS neglected tropical diseases(2021)10.1371/journal.pntd.0009606

N/A

0DataRank · unranked

12 citations

Andrew J. Leidner, Stephen H. Waterman, T. Alex Perkins, Guido España

Costs of Interventions to Increase Vaccination Coverage Among Children in the United States: A Systematic Review

Academic Pediatrics(2021)10.1016/j.acap.2020.11.015

N/A

0DataRank · unranked

7 citations

Andrew J. Leidner, Yuping Tsai, Zhaoli Tang, Bo‐Hyun Cho, Shannon Stokley +1 more

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

MMWR Morbidity and Mortality Weekly Report(2022)10.15585/mmwr.mm7103a2

N/A

0DataRank · unranked

242 citations

Nina B. Masters, Angela Guo, Leah Shepersky, Andrew J. Leidner, Grace M. Lee +3 more

Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years

Value in Health(2022)10.1016/j.jval.2022.08.003

N/A

0DataRank · unranked

9 citations

Tara C. Anderson, Kai Hong, Ismael R. Ortega‐Sanchez, Angela Guo, Jamison Pike +3 more

Trends in costs of routinely recommended vaccines in the United States, 2001–2023

Vaccine(2025)10.1016/j.vaccine.2024.126667

N/A

0DataRank · unranked

3 citations

Andrew J. Leidner, Harrell W. Chesson, RajReni Kaul

Time intervals from vaccine administration to reimbursement for an updated Advisory Committee on Immunization Practices (ACIP) recommendation: Evidence from pneumococcal conjugate vaccinations among privately insured adults, 2021–2022

Vaccine(2025)10.1016/j.vaccine.2025.127665

N/A

0DataRank · unranked

0 citations

Charles M. Carpenter, Tina Trosclair, RajReni Kaul, Bo‐Hyun Cho, Miwako Kobayashi +2 more

Evaluation of temperature stability among different types and grades of vaccine storage units: Data from continuous temperature monitoring devices

Vaccine(2020)10.1016/j.vaccine.2020.02.043

N/A

0DataRank · unranked

11 citations

Helen Fisun, Sean Trimble, P. Marques Lucas, Cameron Noblit, John M. Stevenson +1 more

Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis

Preventive Medicine(2020)10.1016/j.ypmed.2020.106066

N/A

0DataRank · unranked

7 citations

Anna M. Acosta, Andrew J. Leidner, Amanda E. Faulkner, Fangjun Zhou, Bo‐Hyun Cho

Primary Care Use Among Commercially Insured Adolescents: Evidence From the 2018 Healthcare Effectiveness Data and Information Set

American Journal of Preventive Medicine(2020)10.1016/j.amepre.2020.09.013

N/A

0DataRank · unranked

4 citations

Zhaoli Tang, Yuping Tsai, Andrew J. Leidner

Evaluation of non-continuous temperature-monitoring practices for vaccine storage units: a Monte Carlo simulation study

Journal of Public Health(2020)10.1007/s10389-020-01207-0

N/A

0DataRank · unranked

3 citations

Carla E. Lee, Ashley Tippins, Mark L. Messonnier, John M. Stevenson, Andrew J. Leidner

Cost-effectiveness of Dengue Vaccination in Puerto Rico

medRxiv(2020)10.1101/2020.10.07.20208512

N/A

0DataRank · unranked

20 citations

Andrew J. Leidner, Stephen H. Waterman, T. Alex Perkins, Guido España

Andrew J. Leidner

Indexed papers

Top data-sharing exemplar

Papers